An 8-week, double-blind, placebo-controled, multicenter, Ambulatory Blood Pressure Monitoring (ABPM) study of Teveten (Eprosartan Mesylate) 600mg and 1200mg QD in patients with essential hypertension
2005 ◽
Vol 18
(5)
◽
pp. A93-A93
◽
2002 ◽
Vol 24
(1)
◽
pp. 126-138
◽
1992 ◽
Vol 32
(9)
◽
pp. 808-815
◽
2002 ◽
Vol 63
(1)
◽
pp. 1-14
◽
2003 ◽
Vol 23
(7)
◽
pp. 419-430
◽
2009 ◽
Vol 5
(1)
◽
pp. 46-50
1997 ◽
Vol 30
(2)
◽
pp. 176-181
◽
2006 ◽
Vol 60
(4)
◽
pp. 391-398
◽
2005 ◽
Vol 18
(5)
◽
pp. A162-A163